financetom
Business
financetom
/
Business
/
CG Oncology Closes $238 Million Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CG Oncology Closes $238 Million Offering
Dec 16, 2024 2:40 PM

05:28 PM EST, 12/16/2024 (MT Newswires) -- CG Oncology ( CGON ) said Monday it closed a $238 million public offering of 9.2 million shares at $28 apiece.

The offering consists of 8.5 million shares sold by the company, inclusive of 1.2 million shares covered by the underwriters' option to purchase additional shares, and 700,000 shares sold by an existing shareholder, according to a statement.

CG Oncology ( CGON ) said it did not receive any proceeds from the sale of shares by the selling stockholder.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Premarket Gainers
Top Premarket Gainers
Nov 14, 2025
07:37 AM EST, 11/14/2025 (MT Newswires) -- Cidara Therapeutics ( CDTX ) shares were more than 100% higher pre-bell Friday after the company agreed to be acquired by Merck (MRK) in a deal worth about $9.20 billion. Invivyd ( IVVD ) stock was up 55% following a muted session. Binah Capital ( BCG ) shares were 38% higher, a day...
Ionis Pharmaceuticals Says Dawnzera Recommended for Approval in EU for Hereditary Angioedema
Ionis Pharmaceuticals Says Dawnzera Recommended for Approval in EU for Hereditary Angioedema
Nov 14, 2025
07:36 AM EST, 11/14/2025 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) said Friday that it has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use for Dawnzera to prevent recurrent attacks of hereditary angioedema in patients aged 12 years and older. The company said the opinion was based on results from phase...
Sensei Biotherapeutics Q3 loss narrows; reduces workforce by 65%
Sensei Biotherapeutics Q3 loss narrows; reduces workforce by 65%
Nov 14, 2025
Overview * Sensei Biotherapeutics ( SNSE ) reports Q3 net loss of $4.6 mln, down from $7.3 mln last year * Company reduces workforce by 65% to preserve cash Outlook * Sensei Biotherapeutics ( SNSE ) exploring strategic alternatives, including asset sales and potential merger * Company implements workforce reduction to preserve cash amid strategic review * Sensei retains small...
Bitcoin miner LM Funding misses Q3 revenue estimates
Bitcoin miner LM Funding misses Q3 revenue estimates
Nov 14, 2025
Overview * LM Funding Q3 revenue grows 73.5% yr/yr but misses analyst expectations * Net loss for Q3 was $3.7 mln, adjusted EBITDA missed analyst expectations * Company acquired 11 MW Bitcoin mining facility in Mississippi, boosting production Outlook * Company anticipates Oklahoma site expansion to energize in December 2025 * LM Funding expects improved Bitcoin production and efficiency from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved